ArticleScientific reports2024

Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis.

Michael M Poon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.